1.77
1.77 (0%)
As of Apr 17, 2025
Maravai Lifesciences Holdings, Inc. [MRVI]
Source:
Company Overview
Maravai LifeSciences Holdings, Inc. is a leading life sciences company dedicated to providing critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics.
| Country | United States |
| Headquarters | san diego, california |
| Phone Number | (858) 546-0004 |
| Industry | manufacturing |
| CEO | William E. Martin, Iii |
| Website | www.maravai.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $69 |
| Operating Profit | $-165.6 |
| Net Income | $-172.5 |
| Net Cash | $-252.6 |
Profit Ratios
| Gross Margin | $32.2 |
| Operating Margin | -239.9 |
| Profit as % of Revenues | -18.7% |
| Profit as % of Assets | -15.1% |
| Profit as % of Stockholder Equity | -29.9% |
Management Effectiveness
| Return on Equity | -29.9% |
| Return on Assets | -17.1% |
| Turnover Ratio | 6% |
| EBITA | $-165.6 |
Balance Sheet and Cash Flow Measures
| Total Assets | $1,008.2 |
| Total Liabilities | $431 |
| Operating Cash Flow | $7.5 |
| Investing Cash Flow | $-24.3 |
| Financing Cash Flow | $-235.7 |
